Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality
Purpose Allogeneic stem cell transplant (allo-HSCT) patients are at risk of malnutrition and weight loss from impaired oral intake resulting from gastrointestinal toxicities, dysgeusia, and psychological effects. Methods A retrospective review of 264 adult patients transplanted at Princess Margaret...
Gespeichert in:
| Veröffentlicht in: | SUPPORTIVE CARE IN CANCER 2023-10, Vol.31 (10), p.564-564, Article 564 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 564 |
|---|---|
| container_issue | 10 |
| container_start_page | 564 |
| container_title | SUPPORTIVE CARE IN CANCER |
| container_volume | 31 |
| creator | Madsen, Kayla Lee, Katherine Chen, Shiyi Chen, Carol Law, Arjun Datt Gerbitz, Armin Kumar, Rajat Kim, Dennis Lam, Wilson Pasic, Ivan Viswabandya, Auro Michelis, Fotios V. Nampoothiri, Ram Vasudevan Lipton, Jeffrey H. Novitzky-Basso, Igor Mattsson, Jonas |
| description | Purpose
Allogeneic stem cell transplant (allo-HSCT) patients are at risk of malnutrition and weight loss from impaired oral intake resulting from gastrointestinal toxicities, dysgeusia, and psychological effects.
Methods
A retrospective review of 264 adult patients transplanted at Princess Margaret Cancer Centre who achieved relapse-free survival up to 3 months after allo-HSCT was performed.
Results
Overall incidence of patients who experienced WL (WL) ≥ 10% from HSCT to 3-month post-transplant was 45.9% and from HSCT to 6 months was 56.6%. Patients with ≥ 10% WL from allo-HSCT at 3 months and 6 months had similar 2-year overall survival (OS) compared to those with |
| doi_str_mv | 10.1007/s00520-023-08022-9 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_swepu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2862197872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A764019729</galeid><sourcerecordid>A764019729</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-85ed970be1b238ff7970decbde22002cb7c464bbae28033142d5c518857848233</originalsourceid><addsrcrecordid>eNp9kk2LHCEQhpuQQCab_IGchFxycVNq92gflyVfsLCXhBzFtqtnndjaUYdl_33snSFDQlg8aBXPW1SVb9O8ZXDJAOSHDNBxoMAFBQWc0_5Zs2GtEFQK0T9vNtC3jLai6142r3LeAzApO75p9j_Q7e4K8TFnssRcqPE-7jCgsyQXnIlF70lJJuTFm1CIy8TkHK0zBUdy78odccEmNLmGZ44m9I_EHFMx3pWH182LyfiMb073RfP908dv11_oze3nr9dXN9S2oApVHY69hAHZwIWaJlmDEe0wIucA3A7Sttt2GAxyBUKwlo-d7ZhSnVSt4kJcNPRYN9_jchj0ktxs0oOOxulT6md9oVZc1t1V_v2RX1L8dcBc9OzyOrUJGA9Zc7XlrJdK8oq--wfdx0MKdZqVYv3KwJnaGY_ahSnWtdi1qL6S2xZqMd5X6vI_VD0jzs7GgJOr-b8E_CiwqX5WwunPZAz06gJ9dIGuLtCPLtCrSJyWUeGww3Tu-AnVb1wptO0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2861987230</pqid></control><display><type>article</type><title>Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality</title><source>SpringerLink Journals</source><creator>Madsen, Kayla ; Lee, Katherine ; Chen, Shiyi ; Chen, Carol ; Law, Arjun Datt ; Gerbitz, Armin ; Kumar, Rajat ; Kim, Dennis ; Lam, Wilson ; Pasic, Ivan ; Viswabandya, Auro ; Michelis, Fotios V. ; Nampoothiri, Ram Vasudevan ; Lipton, Jeffrey H. ; Novitzky-Basso, Igor ; Mattsson, Jonas</creator><creatorcontrib>Madsen, Kayla ; Lee, Katherine ; Chen, Shiyi ; Chen, Carol ; Law, Arjun Datt ; Gerbitz, Armin ; Kumar, Rajat ; Kim, Dennis ; Lam, Wilson ; Pasic, Ivan ; Viswabandya, Auro ; Michelis, Fotios V. ; Nampoothiri, Ram Vasudevan ; Lipton, Jeffrey H. ; Novitzky-Basso, Igor ; Mattsson, Jonas</creatorcontrib><description>Purpose
Allogeneic stem cell transplant (allo-HSCT) patients are at risk of malnutrition and weight loss from impaired oral intake resulting from gastrointestinal toxicities, dysgeusia, and psychological effects.
Methods
A retrospective review of 264 adult patients transplanted at Princess Margaret Cancer Centre who achieved relapse-free survival up to 3 months after allo-HSCT was performed.
Results
Overall incidence of patients who experienced WL (WL) ≥ 10% from HSCT to 3-month post-transplant was 45.9% and from HSCT to 6 months was 56.6%. Patients with ≥ 10% WL from allo-HSCT at 3 months and 6 months had similar 2-year overall survival (OS) compared to those with < 10% WL, 55.7% vs 62.8% (HR = 1.38,
p
= 0.11) and 71.1% vs 77.2% (HR = 1.37,
p
= 0.27), respectively. Patients with ≥ 10% WL 3 and 6 months from allo-HSCT also had similar 2-year relapse-free survival (RFS) compared to those with < 10% WL, 48.1% vs 55.8% (HR = 1.26,
p
= 0.22), and 62.7% vs 69.8% (HR = 1.29,
p
= 0.31), respectively.
The 2-year transplant-related mortality (TRM) was higher for those with ≥ 10% WL from allo-HSCT to 3 months, 35.4% vs 16.9% (HR = 2.39,
p
= 0.0007) and 6 months, 22% vs 8% (HR = 3.1,
p
= 0.0034). Although statistical significance was not observed for OS or RFS, patients who experienced ≥ 10% WL 3- and 6-months post allo-HSCT experienced higher 2-year TRM. These results highlight the importance of early intervention and close monitoring of weight post allo-HSCT.
Conclusion
Approaches to WL post allo-HSCT should be multifaceted and include members of the interdisciplinary team in order to decrease TRM.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-023-08022-9</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antithymocyte globulin ; Clinical outcomes ; Health aspects ; Health risks ; Malnutrition ; Medicine ; Medicine & Public Health ; Mortality ; Nursing ; Nursing Research ; Oncology ; Pain Medicine ; Palliative care ; Pentamidine isethionate ; Posaconazole ; Rehabilitation Medicine ; Stem cell transplantation ; Stem cells ; Transplantation ; Weight</subject><ispartof>SUPPORTIVE CARE IN CANCER, 2023-10, Vol.31 (10), p.564-564, Article 564</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>COPYRIGHT 2023 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c408t-85ed970be1b238ff7970decbde22002cb7c464bbae28033142d5c518857848233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-023-08022-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-023-08022-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,882,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:154375487$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Madsen, Kayla</creatorcontrib><creatorcontrib>Lee, Katherine</creatorcontrib><creatorcontrib>Chen, Shiyi</creatorcontrib><creatorcontrib>Chen, Carol</creatorcontrib><creatorcontrib>Law, Arjun Datt</creatorcontrib><creatorcontrib>Gerbitz, Armin</creatorcontrib><creatorcontrib>Kumar, Rajat</creatorcontrib><creatorcontrib>Kim, Dennis</creatorcontrib><creatorcontrib>Lam, Wilson</creatorcontrib><creatorcontrib>Pasic, Ivan</creatorcontrib><creatorcontrib>Viswabandya, Auro</creatorcontrib><creatorcontrib>Michelis, Fotios V.</creatorcontrib><creatorcontrib>Nampoothiri, Ram Vasudevan</creatorcontrib><creatorcontrib>Lipton, Jeffrey H.</creatorcontrib><creatorcontrib>Novitzky-Basso, Igor</creatorcontrib><creatorcontrib>Mattsson, Jonas</creatorcontrib><title>Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality</title><title>SUPPORTIVE CARE IN CANCER</title><addtitle>Support Care Cancer</addtitle><description>Purpose
Allogeneic stem cell transplant (allo-HSCT) patients are at risk of malnutrition and weight loss from impaired oral intake resulting from gastrointestinal toxicities, dysgeusia, and psychological effects.
Methods
A retrospective review of 264 adult patients transplanted at Princess Margaret Cancer Centre who achieved relapse-free survival up to 3 months after allo-HSCT was performed.
Results
Overall incidence of patients who experienced WL (WL) ≥ 10% from HSCT to 3-month post-transplant was 45.9% and from HSCT to 6 months was 56.6%. Patients with ≥ 10% WL from allo-HSCT at 3 months and 6 months had similar 2-year overall survival (OS) compared to those with < 10% WL, 55.7% vs 62.8% (HR = 1.38,
p
= 0.11) and 71.1% vs 77.2% (HR = 1.37,
p
= 0.27), respectively. Patients with ≥ 10% WL 3 and 6 months from allo-HSCT also had similar 2-year relapse-free survival (RFS) compared to those with < 10% WL, 48.1% vs 55.8% (HR = 1.26,
p
= 0.22), and 62.7% vs 69.8% (HR = 1.29,
p
= 0.31), respectively.
The 2-year transplant-related mortality (TRM) was higher for those with ≥ 10% WL from allo-HSCT to 3 months, 35.4% vs 16.9% (HR = 2.39,
p
= 0.0007) and 6 months, 22% vs 8% (HR = 3.1,
p
= 0.0034). Although statistical significance was not observed for OS or RFS, patients who experienced ≥ 10% WL 3- and 6-months post allo-HSCT experienced higher 2-year TRM. These results highlight the importance of early intervention and close monitoring of weight post allo-HSCT.
Conclusion
Approaches to WL post allo-HSCT should be multifaceted and include members of the interdisciplinary team in order to decrease TRM.</description><subject>Antithymocyte globulin</subject><subject>Clinical outcomes</subject><subject>Health aspects</subject><subject>Health risks</subject><subject>Malnutrition</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mortality</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Pain Medicine</subject><subject>Palliative care</subject><subject>Pentamidine isethionate</subject><subject>Posaconazole</subject><subject>Rehabilitation Medicine</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Transplantation</subject><subject>Weight</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kk2LHCEQhpuQQCab_IGchFxycVNq92gflyVfsLCXhBzFtqtnndjaUYdl_33snSFDQlg8aBXPW1SVb9O8ZXDJAOSHDNBxoMAFBQWc0_5Zs2GtEFQK0T9vNtC3jLai6142r3LeAzApO75p9j_Q7e4K8TFnssRcqPE-7jCgsyQXnIlF70lJJuTFm1CIy8TkHK0zBUdy78odccEmNLmGZ44m9I_EHFMx3pWH182LyfiMb073RfP908dv11_oze3nr9dXN9S2oApVHY69hAHZwIWaJlmDEe0wIucA3A7Sttt2GAxyBUKwlo-d7ZhSnVSt4kJcNPRYN9_jchj0ktxs0oOOxulT6md9oVZc1t1V_v2RX1L8dcBc9OzyOrUJGA9Zc7XlrJdK8oq--wfdx0MKdZqVYv3KwJnaGY_ahSnWtdi1qL6S2xZqMd5X6vI_VD0jzs7GgJOr-b8E_CiwqX5WwunPZAz06gJ9dIGuLtCPLtCrSJyWUeGww3Tu-AnVb1wptO0</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Madsen, Kayla</creator><creator>Lee, Katherine</creator><creator>Chen, Shiyi</creator><creator>Chen, Carol</creator><creator>Law, Arjun Datt</creator><creator>Gerbitz, Armin</creator><creator>Kumar, Rajat</creator><creator>Kim, Dennis</creator><creator>Lam, Wilson</creator><creator>Pasic, Ivan</creator><creator>Viswabandya, Auro</creator><creator>Michelis, Fotios V.</creator><creator>Nampoothiri, Ram Vasudevan</creator><creator>Lipton, Jeffrey H.</creator><creator>Novitzky-Basso, Igor</creator><creator>Mattsson, Jonas</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20231001</creationdate><title>Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality</title><author>Madsen, Kayla ; Lee, Katherine ; Chen, Shiyi ; Chen, Carol ; Law, Arjun Datt ; Gerbitz, Armin ; Kumar, Rajat ; Kim, Dennis ; Lam, Wilson ; Pasic, Ivan ; Viswabandya, Auro ; Michelis, Fotios V. ; Nampoothiri, Ram Vasudevan ; Lipton, Jeffrey H. ; Novitzky-Basso, Igor ; Mattsson, Jonas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-85ed970be1b238ff7970decbde22002cb7c464bbae28033142d5c518857848233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antithymocyte globulin</topic><topic>Clinical outcomes</topic><topic>Health aspects</topic><topic>Health risks</topic><topic>Malnutrition</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mortality</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Pain Medicine</topic><topic>Palliative care</topic><topic>Pentamidine isethionate</topic><topic>Posaconazole</topic><topic>Rehabilitation Medicine</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Transplantation</topic><topic>Weight</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madsen, Kayla</creatorcontrib><creatorcontrib>Lee, Katherine</creatorcontrib><creatorcontrib>Chen, Shiyi</creatorcontrib><creatorcontrib>Chen, Carol</creatorcontrib><creatorcontrib>Law, Arjun Datt</creatorcontrib><creatorcontrib>Gerbitz, Armin</creatorcontrib><creatorcontrib>Kumar, Rajat</creatorcontrib><creatorcontrib>Kim, Dennis</creatorcontrib><creatorcontrib>Lam, Wilson</creatorcontrib><creatorcontrib>Pasic, Ivan</creatorcontrib><creatorcontrib>Viswabandya, Auro</creatorcontrib><creatorcontrib>Michelis, Fotios V.</creatorcontrib><creatorcontrib>Nampoothiri, Ram Vasudevan</creatorcontrib><creatorcontrib>Lipton, Jeffrey H.</creatorcontrib><creatorcontrib>Novitzky-Basso, Igor</creatorcontrib><creatorcontrib>Mattsson, Jonas</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>SUPPORTIVE CARE IN CANCER</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madsen, Kayla</au><au>Lee, Katherine</au><au>Chen, Shiyi</au><au>Chen, Carol</au><au>Law, Arjun Datt</au><au>Gerbitz, Armin</au><au>Kumar, Rajat</au><au>Kim, Dennis</au><au>Lam, Wilson</au><au>Pasic, Ivan</au><au>Viswabandya, Auro</au><au>Michelis, Fotios V.</au><au>Nampoothiri, Ram Vasudevan</au><au>Lipton, Jeffrey H.</au><au>Novitzky-Basso, Igor</au><au>Mattsson, Jonas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality</atitle><jtitle>SUPPORTIVE CARE IN CANCER</jtitle><stitle>Support Care Cancer</stitle><date>2023-10-01</date><risdate>2023</risdate><volume>31</volume><issue>10</issue><spage>564</spage><epage>564</epage><pages>564-564</pages><artnum>564</artnum><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Purpose
Allogeneic stem cell transplant (allo-HSCT) patients are at risk of malnutrition and weight loss from impaired oral intake resulting from gastrointestinal toxicities, dysgeusia, and psychological effects.
Methods
A retrospective review of 264 adult patients transplanted at Princess Margaret Cancer Centre who achieved relapse-free survival up to 3 months after allo-HSCT was performed.
Results
Overall incidence of patients who experienced WL (WL) ≥ 10% from HSCT to 3-month post-transplant was 45.9% and from HSCT to 6 months was 56.6%. Patients with ≥ 10% WL from allo-HSCT at 3 months and 6 months had similar 2-year overall survival (OS) compared to those with < 10% WL, 55.7% vs 62.8% (HR = 1.38,
p
= 0.11) and 71.1% vs 77.2% (HR = 1.37,
p
= 0.27), respectively. Patients with ≥ 10% WL 3 and 6 months from allo-HSCT also had similar 2-year relapse-free survival (RFS) compared to those with < 10% WL, 48.1% vs 55.8% (HR = 1.26,
p
= 0.22), and 62.7% vs 69.8% (HR = 1.29,
p
= 0.31), respectively.
The 2-year transplant-related mortality (TRM) was higher for those with ≥ 10% WL from allo-HSCT to 3 months, 35.4% vs 16.9% (HR = 2.39,
p
= 0.0007) and 6 months, 22% vs 8% (HR = 3.1,
p
= 0.0034). Although statistical significance was not observed for OS or RFS, patients who experienced ≥ 10% WL 3- and 6-months post allo-HSCT experienced higher 2-year TRM. These results highlight the importance of early intervention and close monitoring of weight post allo-HSCT.
Conclusion
Approaches to WL post allo-HSCT should be multifaceted and include members of the interdisciplinary team in order to decrease TRM.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s00520-023-08022-9</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | SUPPORTIVE CARE IN CANCER, 2023-10, Vol.31 (10), p.564-564, Article 564 |
| issn | 0941-4355 1433-7339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2862197872 |
| source | SpringerLink Journals |
| subjects | Antithymocyte globulin Clinical outcomes Health aspects Health risks Malnutrition Medicine Medicine & Public Health Mortality Nursing Nursing Research Oncology Pain Medicine Palliative care Pentamidine isethionate Posaconazole Rehabilitation Medicine Stem cell transplantation Stem cells Transplantation Weight |
| title | Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A27%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Weight%20loss%20post-allogeneic%20stem%20cell%20transplant%20is%20associated%20with%20increased%20transplant-related%20mortality&rft.jtitle=SUPPORTIVE%20CARE%20IN%20CANCER&rft.au=Madsen,%20Kayla&rft.date=2023-10-01&rft.volume=31&rft.issue=10&rft.spage=564&rft.epage=564&rft.pages=564-564&rft.artnum=564&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-023-08022-9&rft_dat=%3Cgale_swepu%3EA764019729%3C/gale_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2861987230&rft_id=info:pmid/&rft_galeid=A764019729&rfr_iscdi=true |